Literature DB >> 15693217

Respiratory syncytial virus: old challenges and new approaches.

Susana Chávez-Bueno1, Asunción Mejías, Hasan S Jafri, Octavio Ramilo.   

Abstract

Better therapies and prevention strategies are needed to decrease the burden of acute RSV disease in all age populations worldwide. Furthermore, we can hypothesize that those improved measures also would likely have an effect on the chronic consequences of RSV infection in children and will reduce the incidence of recurrent wheezing and persistent pulmonary function abnormalities caused by RSV LRIs.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15693217     DOI： 10.3928/0090-4481-20050101-14

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN： 0090-4481            Impact factor:   1.132


  4 in total

Review 1.  Respiratory syncytial virus bronchiolitis.

Authors:  Alexander K C Leung; James D Kellner; H Dele Davies
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

2.  Viral infection of the lungs through the eye.

Authors:  Vira Bitko; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

3.  Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection.

Authors:  Birthe Jessen; Simone Faller; Christine D Krempl; Stephan Ehl
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Authors:  Wenliang Zhang; Youngjoo Choi; Lia M Haynes; Jennifer L Harcourt; Larry J Anderson; Les P Jones; Ralph A Tripp
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.